Detalhe da pesquisa
1.
Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation.
Blood
; 140(10): 1167-1181, 2022 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35853161
2.
Chimeric antigen receptor T cells for acute myeloid leukemia.
Eur J Haematol
; 112(1): 28-35, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37455578
3.
Targeting TGFß-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome.
Nat Cancer
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38741011